Stock listing
NASDAQ:ICVX Icosavax Inc Stock
Follow Icosavax Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ICVX
$15.31 USD
Close on Feb 29, 2024 · No longer trades
- Lowest – highest close
- $2.32 – $40.25 USDSince Jul 29, 2021 · lowest Nov 14, 2022 · highest Aug 23, 2021
Delisted NASDAQ:ICVX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ICVX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Icosavax Inc on 6ix
- Decks
- 6 decks · latest Aug 8, 2023
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (August 2023) | Corporate update | 15 slides | Aug 8, 2023 |
| Technical Presentation (May 2023) | Technical | 29 slides | May 22, 2023 |
| Technical Presentation (December 2022) | Technical | 11 slides | Dec 13, 2022 |
| Technical Presentation (June 2022) | Technical | 27 slides | Jun 28, 2022 |
| Investor Presentation (April 2022) | Investor deck | 41 slides | Apr 25, 2022 |
| Investor Presentation (November 2021) | Investor deck | 33 slides | Nov 18, 2021 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Jul 28, 2021 – Feb 19, 2024 · Past |
| Heidi Fields Other companies: Phathom Pharmaceuticals, Inc. (Director · Since at least May 25, 2022); Agilent Technologies, Inc. (Director · Nov 23, 2022 – Mar 14, 2025 · Past) | Director · Jun 10, 2022 – Jun 6, 2023 · Past |
| Amin Khan Other companies: Greenlight Biosciences Holdings PBC (Chief Scientific Officer · Feb 2, 2022 – May 10, 2022 · Past) | EVP, Head of Research & Dev. · Jun 12, 2023 – Jun 12, 2023 · Past |
| Elizabeth Bekiroglu Other companies: Jade Biosciences, Inc. (See Remarks · Since at least Apr 28, 2025) | General Counsel & Corp. Sec. · Sep 21, 2021 – Feb 15, 2023 · Past |
| Jim Wassil Other companies: Vaxcyte, Inc. (Executive Vice President, Chief Operating Officer and Chief Scientific Officer · Since at least Jun 11, 2020) | Director · Jun 10, 2022 – Jun 6, 2023 · Past |
| Mark McDade Other companies: Tourmaline Bio Inc. (Director · Since at least Jun 9, 2022) | Director · Apr 1, 2022 – Jun 6, 2023 · Past |
| Adam K Simpson | Chief Executive Officer, Director · Jul 1, 2022 – Jan 30, 2024 · Past |
| Douglas Holtzman | Chief Scientific Officer · Jul 28, 2021 – Jul 3, 2023 · Past |
Log in to ask 6ix AI your own questions about Icosavax Inc.